This Viewpoint discusses the ideals and values that other industries can learn from health care organizations.
This Viewpoint discusses the need for international cooperation in deciding how professional societies, academic medical centers, medical groups, and health care systems can best integrate physician-assisted death into their practices.
This Viewpoint discusses a business case for health information exchange and its effects on clinical care and its improvement of patient outcomes.
In this randomized clinical trial, among pregnant women who recently had quit smoking, intervention telephone calls and in-person visits were conducted through 24 weeks’ postpartum, and the relative efficacy of 2 different approaches to prevent postpartum relapse are compared.
This systematic review and meta-analysis of randomized clinical trials assesses the efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women.
This study evaluates the appropriateness of free-text notes added by prescribers in a nationally representative electronic prescribing system used in ambulatory care.
In a nationally representative sample of older adults, this study characterizes changes in the prevalence of medication use and quantifies the frequency and types of potential major drug-drug interactions.
This observational study of general medicine patients readmitted within 30 days of discharge to 12 US academic medical centers investigates preventability of readmissions and uses these estimates to prioritize areas for improvement.
This cohort study tests the HOSPITAL score—a tool to identify likelihood of hospital readmission based on 7 readily available predictors—on 117 065 adults across 4 countries and identifies patients at high risk of 30-day potentially avoidable readmission.
This Danish nationwide cohort study evaluates whether there is excess risk of motor vehicle crashes among patients with syncope compared with the general population.
The China PEACE-Retrospective CathPCI Study evaluates the change in the use of coronary artery catheterization and percutaneous coronary intervention in Chinese urban hospitals.
This national cohort study examines the prevalence, diagnosis, treatment, and control of hypertension and assesses the effect of hypertension on cardiovascular disease mortality among adults in China.
This qualitative study describes the experience of bereaved caregivers and patients at the end of life who have a left ventricular assist device.
This case of a 49-year-old woman who was admitted for presumed methanol poisoning highlights the importance of ordering appropriate investigations and considering an unexpected laboratory value in the context of the patient’s clinical signs and symptoms.
This Teachable Moment discusses the consequences that can arise from antibiotic overuse in the setting of asymptomatic pyuria and misinterpretation of urinalyses.
This Teachable Moment examines the effect of a simple leg raise (volume loading) on the dynamic left ventricular outflow tract and mitral regurgitation.
This study assesses the patterns of complementary and alternative medicine use in the United States and reasons for its nondisclosure.
This survey study compares the use of prostate-specific antigen testing among men aged 50 to 74 years before and after the 2012 United States Preventive Services Task Force guidelines were issued.
This multicenter study examines whether recently developed and evolving guidelines may reduce current substantial variation in indications, patterns of use, and outcomes of the use of peripherally inserted central catheters.
This study examines the publication and reporting of studies supporting novel high-risk cardiovascular devices approved by the US Food and Drug Administration.
This study examines trends for information about human immunodeficiency virus in the mass media and on the Internet after celebrity disclosure of infection with the virus.
This study assesses the trends in physician-assisted suicide and other medical end-of-life practices in Switzerland.
This study describes the characteristics of completed phase 3 or 4 clinical trials in rare diseases registered at clinicaltrials.gov and assesses whether their results are publicly available.
This study quantifies the notifications that physicians received via inboxes of commercial electronic health records to estimate their burden.
Create a personal account or sign in to: